Open AccessAn Evaluation of Biometric Monitoring Technologies for Vital Signs in the Era of COVID‐19
Author(s) -
Manta Christine,
Jain Sneha S.,
Coravos Andrea,
Mendelsohn Dena,
Izmailova Elena S.
Publication year - 2020
Publication title -
clinical and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 44
eISSN - 1752-8062
pISSN - 1752-8054
DOI - 10.1111/cts.12874
Subject(s) - vital signs , data collection , telehealth , biometrics , context (archaeology) , computer science , telemedicine , health care , biometric data , pandemic , covid-19 , medical emergency , medicine , internet privacy , data science , computer security , disease , infectious disease (medical specialty) , pathology , geography , surgery , statistics , mathematics , archaeology , economics , economic growth
The novel coronavirus disease 2019 (COVID‐19) global pandemic has shifted how many patients receive outpatient care. Telehealth and remote monitoring have become more prevalent, and measurements taken in a patient’s home using biometric monitoring technologies (BioMeTs) offer convenient opportunities to collect vital sign data. Healthcare providers may lack prior experience using BioMeTs in remote patient care, and, therefore, may be unfamiliar with the many versions of BioMeTs, novel data collection protocols, and context of the values collected. To make informed patient care decisions based on the biometric data collected remotely, it is important to understand the engineering solutions embedded in the products, data collection protocols, form factors (physical size and shape), data quality considerations, and availability of validation information. This article provides an overview of BioMeTs available for collecting vital signs (temperature, heart rate, blood pressure, oxygen saturation, and respiratory rate) and discusses the strengths and limitations of continuous monitoring. We provide considerations for remote data collection and sources of validation information to guide BioMeT use in the era of COVID‐19 and beyond.